Who is the manufacturer of Straumann Immediate Temporary Abutments?

Institut Straumann AG filed the 510(k) submission for Straumann Immediate Temporary Abutments (K201681).

What is the FDA product code for Straumann Immediate Temporary Abutments?

NHA. It is classified under 21 CFR 872.3630 as a Class 2 device in the Dental panel.

What is the regulatory pathway for Straumann Immediate Temporary Abutments?

510(k) clearance (submission type: Traditional).

What are the predicate devices for Straumann Immediate Temporary Abutments?

Straumann Temporary Abutments, PMMA (K122192).

Who can help prepare an FDA 510(k) submission like Straumann Immediate Temporary Abutments?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

Straumann Immediate Temporary Abutments

K201681 · Institut Straumann AG · NHA · Mar 18, 2021 · Dental

Device Facts

Record ID	K201681
Device Name	Straumann Immediate Temporary Abutments
Applicant	Institut Straumann AG
Product Code	NHA · Dental
Decision Date	Mar 18, 2021
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 872.3630
Device Class	Class 2
Attributes	Therapeutic

Intended Use

The Straumann Immediate Temporary Abutment and associated Plastic Coping are indicated to be placed into Straumann dental implants (BL, BLT or BLX) to provide a support structure for a temporary aesthetic oral rehabilitation of partially edentulous patients with crowns. Temporary components can be used prior to the final components to maintain, stabilize and shape the soft tissue during the healing phase for up to 180 days. The Straumann Immediate Temporary Abutment and associated Plastic Coping must be placed out of occlusion.

Device Story

Device consists of titanium (Ti-6Al-7Nb) abutment and PMMA plastic coping; used with Straumann dental implants (BL, BLT, BLX). Abutment is one-piece design, screwed directly into implant; provides support structure for temporary crowns. Used in dental clinics by clinicians to maintain/shape soft tissue during healing phase (up to 180 days). Must be placed out of occlusion. Abutments provided sterile (gamma irradiation); copings provided non-sterile, requiring manual cleaning/disinfection by user. Output is a stable temporary prosthetic base; aids clinical decision-making by facilitating soft tissue management prior to final restoration.

Clinical Evidence

Bench testing only. Biocompatibility assessed per ISO 10993-1, ISO 10993-5 (cytotoxicity), and ISO 10993-18 (chemical characterization). Sterilization validation performed per ISO 11137 for abutments; high-level disinfectant validation performed for PMMA copings. MRI compatibility established via reference to K190662.

Technological Characteristics

Materials: Ti-6Al-7Nb (abutment), PMMA (coping). Design: One-piece abutment, non-engaging. Sterilization: Gamma irradiation (abutment), manual cleaning/disinfection (coping). Shelf life: 5 years. MRI conditional.

Indications for Use

Indicated for partially edentulous patients requiring temporary aesthetic oral rehabilitation with crowns using Straumann dental implants (BL, BLT, or BLX). Components maintain, stabilize, and shape soft tissue during healing for up to 180 days. Contraindicated for use in occlusion.

Regulatory Classification

Identification

An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.

Special Controls

*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)

Predicate Devices

Straumann Temporary Abutments, PMMA (K122192)

Reference Devices

Straumann Screw Retained Abutments (K192401)
BLX Implant System (K181703)
MRI Compatibility for Existing Straumann Dental Implant System (K190662)
Straumann Temporary Coping (K041070)

Related Devices

K220751 — Straumann BLX Temporary Abutment, VITA CAD-Temp, PMMA · Institut Straumann AG · Jun 2, 2022
K070478 — P.004 RC TEMPORARY ABUTMENT, P.004 TEMPORARY HEALING ABUTMENT (CAP) · Straumann Manufacturing, Inc. · Sep 20, 2007
K122192 — NC TEMPORARY ABUTMENT, CAD-TEMP, PMMA RC TEMPORARY ABUTMENT, CAD-TEMP, PMMA RN TEMPORARY ABUTMENT, CAD-TEMP, PMMA WN TEM · Straumann USA, LLC · Nov 2, 2012
K072679 — P.004 ABUTMENTS · Institut Straumann AG · Oct 12, 2007
K041070 — STRAUMANN TEMPORARY COPING · The Straumann Co. · Jul 23, 2004

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. March 18, 2021 Institut Straumann AG % Chanrasmey White Regulatory Affairs Specialist Straumann USA, LLC 60 Minuteman Road Andover, Massachusetts 01801 Re: K201681 Trade/Device Name: Straumann Immediate Temporary Abutments Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: Class II Product Code: NHA Dated: February 12, 2021 Received: February 16, 2021 Dear Chanrasmey White: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Srinivas Nandkumar, Ph.D. Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ### Indications for Use 510(k) Number (if known) K201681 Device Name Straumann® Immediate Temporary Abutments #### Indications for Use (Describe) The Straumann Immediate Temporary Abutment and associated Plastic Coping are indicated to be placed into Straumann dental implants (BL, BLT or BLX) to provide a support structure for a temporary aesthetic oral rehabilitation of partially edentulous patients with crowns. Temporary components can be used prior to the final components to maintain, stabilize and shape the soft tissue during the healing phase for up to 180 days. The Straumann Immediate Temporary Abutment and associated Plastic Coping must be placed out of occlusion. | Type of Use (Select one or both, as applicable) | | |-------------------------------------------------|---------------------------------------------| | X Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ ## Straumann® Immediate Temporary Abutments 510(k) Summary #### K201681 510(k) Summary 5 #### Submitter 5.1 60 Minuteman Road Andover, MA 01810 978-747-0023 Fax Number: - Contact Person: Chanrasmey White March 17, 2021 Date of Prepared: #### 5.2 Device | Trade Name: | Straumann® Immediate Temporary Abutments | |----------------------|------------------------------------------| | Common Name: | Endosseous Dental Implant Abutments | | Classification Name: | Endosseous Dental Implant Abutments | | Regulatory Class: | II (21 CFR 872.3630) | | Product Code: | NHA (21 CFR 872.3630) | #### 5.3 Predicate Device Primary Predicate: - K122192 Straumann Temporary Abutments, PMMA Reference Predicate: - K192401 Straumann Screw Retained Abutments - K181703 BLX Implant System - K190662 MRI Compatibility for Existing Straumann Dental Implant System - K041070 Straumann Temporary Coping {4}------------------------------------------------ ### Straumann® Immediate Temporary Abutments 510(k) Summary #### Device Description 5.4 The Straumann Immediate Temporary Abutment and associated Plastic Copinq consist of a titanium abutment and PMMA coping for the Straumann dental implants BL, BLT and BLX. The abutments are available in a variety of gingival heights and diameters to fit individual patient situations. The PMMA coping is compatible with the subject Immediate Temporary Abutments. The Straumann Immediate Temporary Abutment and associated Plastic Coping are indicated to provide a support structure for a temporary aesthetic oral rehabilitation of partially edentulous patients with crowns. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase for up to 180 days. #### 5.5 Indications for Use The Straumann Immediate Temporary Abutment and associated Plastic Coping are indicated to be placed into Straumann dental implants (BL, BLT or BLX) to provide a support structure for a temporary aesthetic oral rehabilitation of partially edentulous patients with crowns. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase for up to 180 days. The Straumann Immediate Temporary Abutment and associated Plastic Coping must be placed out of occlusion. ### 5.6 Technological Characteristics The subject device is equivalent to the primary predicate and reference devices sharing the same material and fundamental operating principles. The differences in indications for use are addressed in performance testing provided in this submission demonstrating equivalent product performance. The subject and the primary predicate devices are intended to support temporary prosthetic reconstructions. The subject devices have a contact duration of up to 180 days compared to the primary predicate and reference devices, biocompatibility testing has been performed to support the 180 duration of use. The technological characteristics of the subject device are compared to the primary predicate and reference devices in Table 2. The subject devices are one-piece abutments opposed to the two-piece temporary abutments cleared per K122192. The one-piece design allows the abutment to be directly screwed into the {5}------------------------------------------------ ## Straumann® Immediate Temporary Abutments 510(k) Summary implant. The differences in technological differences are addressed in the performance testing provided in the submission which demonstrates equivalency in product performance. {6}------------------------------------------------ ## Straumann® Immediate Temporary Abutments 510(k) Summary | FEATURE | PROPOSED DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE DEVICE | REFERENCE DEVICE | |--------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | K Number | Subject Device | K122192 | K192401 | K181703 | | Indications for Use | The Straumann Immediate Temporary Abutment and associated Plastic Coping are indicated to be placed into Straumann dental implants (BL, BLT or BLX) to provide a support structure for a temporary aesthetic oral rehabilitation of partially edentulous patients with crowns. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase for up to 180 days. The Straumann Immediate Temporary Abutment and associated Plastic Coping must be placed out of occlusion. | Straumann Temporary Abutments VITA CAD-Temp are indicated for use with Straumann Bone Level and Tissue Level implants for temporary crown and bridge restorations, and to maintain, stabilize and shape the soft tissue during the healing phase for up to six months, and should be placed out of occlusion. | Prosthetic components directly or indirectly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they may not be placed into occlusion. Final abutments may be placed into occlusion when the implant is fully osseointegrated. Temporary Abutments have a maximum duration of usage of 180 days. | Straumann® BLX Implants Straumann® BLX Implants are suitable for endosteal implantation in the upper and lower jaw and for the functional and esthetic oral rehabilitation of edentulous and partially edentulous patients. BLX Implants can be placed with immediate function on single-tooth. bar and bridge applications when qood primary stability is achieved and with appropriate occlusal loading to restore chewing function. The prosthetic restorations are connected to the implants through the corresponding abutment components. Straumann® BLX SRAs and Anatomic Abutments Prosthetic components directly or indirectly connected to the endosseous dental implant are intended for use as an aid in prosthetic rehabilitations. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase; they may not be placed into occlusion. Final abutments may be placed into occlusion when the implant is fully osseointegrated. BLX Temporary Abutments have a maximum duration of usage of 180 days. | | Material | Abutment: Ti-6Al-7Nb Plastic Coping: Polymethyl Methacrylate (PMMA) | Ti-6Al-7Nb Polymethyl Methacrylate (PMMA) | Ti-6Al-7Nb | Ti-6Al-7Nb | | Implant Compatibility | BL, BLT, BLX | BL, BLT, TL | BL, BLT | BLX | | FEATURE | PROPOSED DEVICE | PRIMARY PREDICATE DEVICE | REFERENCE DEVICE | REFERENCE DEVICE | | K Number | Subject Device | K122192 | K192401 | K181703 | | Abutment Diameter | Ø3.8 and 4.5 | Ø5.0, 7.0, and 10.0 mm | Ø3.5 and 4.6 mm | Ø4.6 mm | | Gingival Heights | BL and BLT - 1, 2, and 3 mm BLX - 1.5, 2.5, and 3.5 mm | 1.0, 2.5, 4.0, and 5.5 mm | 1.5, 2.5, 3.5, 4.5, and 5.5 mm | 1.5, 2.5, 3.5, and 4.5 mm | | Abutment Angulation | 0° | 0° | 0, 17 and 30° | 0, 17 and 30° | | Indexing Type/ Presence | Non-Engaging | Engaging | Straight - Non-Engaging | Straight - Non-Engaging | | Integrated Screw Technology | Yes Machined one-piece | No Coupled with a base screw | Yes - The straight abutments are machined one-piece | Yes - The straight abutments are machined one-piece | | Restoration Type | Cemented | Cemented | Screw-retained | Screw-retained | | Duration of Use | 180 days | 180 days | unlimited | unlimited | | Sterilization | Sterile - Gamma Irradiation | Non-Sterile End User - Steam Autoclave | Sterile - Gamma Irradiation | Sterile - Gamma Irradiation | | Loading | Single Unit | Single and Multi Unit | Single and Multi Unit | Single and Multi Unit | {7}------------------------------------------------ ## Straumann® Immediate Temporary Abutments ### 510(k) Summary Table 1 – Immediate Temporary Abutment – Comparison Matrix {8}------------------------------------------------ ## Straumann® Immediate Temporary Abutments ### 510(k) Summary | FEATURE | PROPOSED DEVICE | REFERENCE DEVICE | |---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------| | K Number | Subject Device | K041070 | | Indications for Use | The Straumann Immediate Temporary Abutment and associated Plastic Coping are indicated to be placed into Straumann dental implants (BL, BLT or BLX) to provide a support structure for a temporary aesthetic oral rehabilitation of partially edentulous patients with crowns. Temporary components can be used prior to the insertion of the final components to maintain, stabilize and shape the soft tissue during the healing phase for up to 180 days. The Straumann Immediate Temporary Abutment and associated Plastic Coping must be placed out of occlusion. | Temporary Copings are intended to serve as a base for temporary restorations. | | Material | Polymethyl methacrylate (PMMA) | Polymethyl methacrylate (PMMA) | | Restoration Type | Cemented | Cemented | | Duration of Use | 180 days | 30 days | | Sterilization | Non-Sterile Cleaned and disinfected | Non-Sterile | Table 2 – Plastic Coping – Comparison Matrix {9}------------------------------------------------ ### Straumann® Immediate Temporary Abutments 510(k) Summary #### Performance Data 5.7 - The following performance data were provided in support of the substantial equivalence determination. #### Biocompatibility Testing The subject devices have been assessed for biological safety according to ISO 10993-1:2009 "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process" and to the FDA Guidance document "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process', Guidance for Industry and Food and Drug Administration Staff, Document issued on June 16, 2016" for the subject device. The subject abutments are equivalent with regard to nature of body contact, duration of use, material formulation and sterilization methods compared to the primary and reference predicate devices and therefore, no new testing have been performed as biocompatibility is represented in the primary and reference predicate devices. In support of the subject PMMA plastic copings, Cytotoxicity testing according to ISO 10993-5:2009, "Biological evaluation of medical devices – Part 5: Test for in vitro cytotoxicity" and Chemical Analysis according to ISO 10993-18: 2020 "Chemical characterization of medical device materials within a risk management process" has been performed. In addition to the above testing a toxicology evaluation has been performed in support of the subject PMMA plastic copings. The test and evaluation performed the biocompatibility of the subject PMMA plastic copings. #### Sterilization The subject device are single patient devices. The Immediate Temporary Abutments will be delivered in a sterile packaging via Gamma Irradiation and the PMMA plastic coping will be delivered non-sterile. The PMMA plastic coping is to be manually cleaned and disinfected according to the Instructions for Use. A sterilization validation assessment was performed according to ISO 11137 for the Immediate Temporary Abutments. The assessment concluded the proposed Immediate Temporary {10}------------------------------------------------ ## Straumann® Immediate Temporary Abutments ### 510(k) Summary Abutment can be adopted into the same sterilization process validated for the Straumann Sterile Prosthetics cleared for reference predicate K192401. A high-level disinfectant validation was performed on the worst case PMMA device. The worst case was selected based on the most challenging designs for high level disinfection process due to size, surface, complexity and accessibility of the liquid solution. The subject PMMA Plastic Coping is not considered a new worst case and therefore can adopt the validation demonstrating the high-level disinfectant cleaning method can effectively disinfect the Plastic Coping. The packaging of the Straumann® Immediate Temporary Abutments is identical to the packaging of the reference device K192401. There are no changes to the sterilization method or production process compared to the reference device. The shelf life for the proposed devices is 5 years identical to the reference device. #### Bench Testing The subject devices are MRI Conditional and do not introduce a new material or worst-case scenario and is represented under reference device K190662. #### Conclusion 5.8 The documentation submitted in this premarket notification demonstrates the subject devices are substantially equivalent to the primary predicate and reference devices.